Company intelligence / Profile preview

PCOStrategies

Washington, District of Columbia, United States

Ownership: Private
Development stage: Other

Overview

PCO Strategies is a specialized healthcare consulting and advocacy firm based in Washington, D.C., that focuses on the 340B Drug Pricing Program and federal healthcare policy. The firm provides strategic advice, policy analysis, and federal advocacy services to healthcare providers, pharmacies, and other stakeholders involved in the 340B ecosystem. Led by Peggy Tighe, PCO Strategies works to protect and strengthen the 340B program through legislative engagement and regulatory guidance. The company is recognized for its expertise in navigating the complex legal and operational landscape of drug pricing and pharmacy services.

Industry: Consulting

Beyond the preview

Go deeper on PCOStrategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PCOStrategies.

Explore the full profile